Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan (vol 43, pg 842, 2008)

被引：0
|
作者：
Suenaga, Mitsukuni [1 ]
Mizunuma, Nobuyuki [1 ]
Shouji, Daigo [1 ]
Shinozaki, Eiji [1 ]
Matsusaka, Satoshi [1 ]
Chin, Keisho [1 ]
Oya, Masatoshi [2 ]
Yamaguchi, Toshiharu [2 ]
Muto, Tetsuichiro [2 ]
Hatake, Kiyohiko [1 ]
机构：
[1] Canc Inst Hosp, Dept Med Oncol, Japanese Fdn Canc Res, Koto Ku, Tokyo 1358550, Japan
[2] Canc Inst Hosp, Div Gastroenterol Surg, Japanese Fdn Canc Res, Tokyo 1358550, Japan
来源：
JOURNAL OF GASTROENTEROLOGY | 2009年 / 44卷 / 07期
关键词：
D O I：
10.1007/s00535-009-0079-x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：801 / 801
页数：1
相关论文
共 50 条
  • [21] Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer
    Kono, T
    Ebisawa, Y
    Tomita, I
    Chisato, N
    Kamiya, K
    Asama, T
    Ayabe, T
    Ashida, T
    Kohgo, Y
    Kasai, S
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 224 - 227
  • [22] Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial (Retraction of vol 25, pg 100, 2007)
    Souglakos, J.
    Vardakis, N.
    Androulakis, N.
    Kakolyris, S.
    Kourousis, C.
    Mavroudis, D.
    Pallis, A.
    Agelaki, S.
    Kalbakis, K.
    Georgoulias, V.
    DIGESTIVE DISEASES, 2008, 26 (02) : 188 - 188
  • [23] Double modulation of 5-fluorouracil by methotrexate and high-dose L-leucovorin in advanced colorectal cancer
    Romero, AO
    Perez, JE
    Cuevas, MA
    Lacava, JA
    Sabatini, CL
    Dominguez, ME
    Rodriguez, R
    Barbieri, MR
    Ortiz, EH
    Salvadori, MA
    Acuna, LAR
    Acuna, JMR
    Langhi, MJ
    Amato, S
    Machiavelli, MR
    Leone, BA
    Vallejo, CT
    Lorusso, V
    DeLena, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01): : 94 - 98
  • [24] Multicenter phase II study of irinotecan plus weekly bolus 5-FU and high dose l-leucovorin for patients with metastatic colorectal cancer (OGSG 0201).
    Ishida, H
    Mishima, H
    Iwamoto, S
    Morimoto, T
    Kato, T
    Tsujinaka, T
    Furukawa, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 298S - 298S
  • [25] RETRACTED: Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial (Retracted Article. See vol 26, pg 188, 2008)
    Souglakos, J.
    Vardakis, N.
    Androulakis, N.
    Kakolyris, S.
    Kourousis, C.
    Mavroudis, D.
    Pallis, A.
    Agelaki, S.
    Kalbakis, K.
    Georgoulias, V.
    DIGESTIVE DISEASES, 2007, 25 (01) : 100 - 105
  • [26] Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin
    Hubner, Richard A.
    Cubillo, Antonio
    Blanc, Jean-Frederic
    Melisi, Davide
    Von Hoff, Daniel D.
    Wang-Gillam, Andrea
    Chen, Li-Tzong
    Becker, Claus
    Mamlouk, Khalid
    Belanger, Bruce
    Yang, Yoojung
    de Jong, Floris A.
    Siveke, Jens T.
    EUROPEAN JOURNAL OF CANCER, 2019, 106 : 24 - 33
  • [27] Panitumumab therapy with irinotecan, 5-fluorouracil, and leucovorin (IFL) in patients (pts) with metastatic colorectal cancer (mCRC)
    Berlin, Jordan
    Malik, Imtiaz
    Picus, Joel
    Glisson, Shawn
    Kozloff, Mark
    Spitzer, Gary
    Wiens, Brian
    MacDonald, Monica
    Jerian, Susan
    Hecht, J. Randolph
    ANNALS OF ONCOLOGY, 2004, 15 : 70 - 71
  • [28] Chemotherapy with 5-Fluorouracil(S-FU) plus L-Leucovorin(L-LV) for inoperable gastric cancer
    Mizuno, I
    Mohri, N
    Terada, J
    Ueda, T
    Akamo, Y
    Shibata, T
    Ishikawa, M
    Takeyama, H
    Manabe, T
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 1535 - 1539
  • [29] A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
    Van Cutsem, E
    Pozzo, C
    Starkhammar, H
    Dirix, L
    Terzoli, E
    Cognetti, E
    Humblet, Y
    Garufi, C
    Filez, L
    Gruia, G
    Cote, C
    Barone, C
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1199 - 1204
  • [30] Meta-analysis comparing the safety and efficacy of metastatic colorectal cancer treatment regimens, capecitabine plus irinotecan (CAPIRI) and 5-fluorouracil/leucovorin plus irinotecan (FOLFIRI)
    Ding, Hong-hua
    Wu, Wei-dong
    Jiang, Tao
    Cao, Jun
    Ji, Zheng-yi
    Jin, Jia-huan
    Wang, Jing-jue
    Song, Wei-feng
    Wang, Li-wei
    TUMOR BIOLOGY, 2015, 36 (05) : 3361 - 3369
12345